about
BeyondSpring Inc is engaged in clinical-stage biopharmaceutical activities focused on the development of cancer therapies. It is also focused on including immuno-oncology agents. It operates in Plinabulin pipeline segment.
Read More
1.69
0.06
(3.68%)
26,448.4
XNAS Volume
XNAS 13 Mar, 2026 1:13 PM (EDT)
Not Eligible
Expensive Valuation
Technically Neutral
BeyondSpring Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..